The World Health Organization released recommendations in 2015 to ensure all HIV-positive persons, regardless of disease status, initiated lifelong treatment. In this issue of Haba Na Haba, EGPAF explores the impact of this all-inclusive treatment protocol, best practices in growing treatment access in our own supported countries and charts a way forward to effectively implement these new guidelines in a variety of settings.
Explore Related Resources
Resource
Effectiveness of a Multi-component Facility-based Intervention on HIV-related Infant and Maternal Outcomes
Published April 2025
Introduction Even in the context of widespread access to prevention of vertical HIV transmission (PVT) services, health system challenges compromise health outcomes for women living with HIV and their children. The “Integrated Management Team to Improve Maternal-Child Outcomes” (IMPROVE) study measured the effect of a package of facility-based interventions on PVT and maternal and child […]
View Resource
Countries:
Lesotho
Journal Articles
Assessing Time Requirements of Two Models of SARS-CoV- 2 Screening and Testing in Routine Healthcare Services in Kenya and Cameroon
Published March 2025
Introduction Incorporating SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs) into routine care settings can facilitate efficient case identification and management in low-resource settings. We assessed the time required to complete SARS-CoV-2 screening and Ag-RDT testing in maternal, neonatal and child health (MNCH), HIV and tuberculosis clinics in selected facilities in Kenya and Cameroon. Methods We conducted […]
View Resource
Countries:
Cameroon,
Kenya
Journal Articles
Birth Defects and Adverse Pregnancy Outcomes in Hospital-based Birth Surveillance in Eswatini
Published February 2025
Background The Botswana Tsepamo study identified an initial neural tube defect (NTD) safety signal with dolutegravir antiretroviral therapy (ART) exposure at conception. We conducted similar surveillance in 5 hospitals in Eswatini from September 2021 to September 2023 to evaluate the prevalence of birth defects and adverse pregnancy outcomes by maternal HIV status and ART regimen/timing. […]
View Resource
Countries:
Eswatini